Epidermal growth factor receptor (EGFR) is the most prominent driving gene in non-small-cell lung cancer (NSCLC), mainly including EGFR exon 19 deletion and L858R mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.